Your browser doesn't support javascript.
loading
Identification of bacteria-derived HLA-bound peptides in melanoma.
Kalaora, Shelly; Nagler, Adi; Nejman, Deborah; Alon, Michal; Barbolin, Chaya; Barnea, Eilon; Ketelaars, Steven L C; Cheng, Kuoyuan; Vervier, Kevin; Shental, Noam; Bussi, Yuval; Rotkopf, Ron; Levy, Ronen; Benedek, Gil; Trabish, Sophie; Dadosh, Tali; Levin-Zaidman, Smadar; Geller, Leore T; Wang, Kun; Greenberg, Polina; Yagel, Gal; Peri, Aviyah; Fuks, Garold; Bhardwaj, Neerupma; Reuben, Alexandre; Hermida, Leandro; Johnson, Sarah B; Galloway-Peña, Jessica R; Shropshire, William C; Bernatchez, Chantale; Haymaker, Cara; Arora, Reetakshi; Roitman, Lior; Eilam, Raya; Weinberger, Adina; Lotan-Pompan, Maya; Lotem, Michal; Admon, Arie; Levin, Yishai; Lawley, Trevor D; Adams, David J; Levesque, Mitchell P; Besser, Michal J; Schachter, Jacob; Golani, Ofra; Segal, Eran; Geva-Zatorsky, Naama; Ruppin, Eytan; Kvistborg, Pia; Peterson, Scott N.
Afiliação
  • Kalaora S; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Nagler A; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Nejman D; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Alon M; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Barbolin C; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Barnea E; Department of Biology, Technion - Israel Institute of Technology, Haifa, Israel.
  • Ketelaars SLC; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Cheng K; Cancer Data Science Laboratory (CDSL), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA.
  • Vervier K; Wellcome Sanger Institute, Cambridge, UK.
  • Shental N; Department of Mathematics and Computer Science, Open University of Israel, Raanana, Israel.
  • Bussi Y; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Rotkopf R; Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.
  • Levy R; Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.
  • Benedek G; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Trabish S; Tissue Typing and Immunogenetics Unit, Hadassah Medical Center, Jerusalem, Israel.
  • Dadosh T; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Levin-Zaidman S; Department of Chemical Research Support, Weizmann Institute of Science, Rehovot, Israel.
  • Geller LT; Department of Chemical Research Support, Weizmann Institute of Science, Rehovot, Israel.
  • Wang K; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Greenberg P; Cancer Data Science Laboratory (CDSL), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA.
  • Yagel G; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Peri A; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Fuks G; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Bhardwaj N; Department of Physics of Complex Systems, Weizmann Institute of Science, Rehovot, Israel.
  • Reuben A; The Ruth and Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.
  • Hermida L; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Johnson SB; Cancer Data Science Laboratory (CDSL), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA.
  • Galloway-Peña JR; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Shropshire WC; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Bernatchez C; Department of Veterinary Pathobiology, Texas A&M University, Houston, TX, USA.
  • Haymaker C; Department of Infectious Diseases, MD Anderson Cancer Center, Houston, TX, USA.
  • Arora R; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Roitman L; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Eilam R; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Weinberger A; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lotan-Pompan M; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Lotem M; Department of Veterinary Resources, Weizmann Institute of Science, Rehovot, Israel.
  • Admon A; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Levin Y; Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.
  • Lawley TD; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Adams DJ; Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.
  • Levesque MP; Sharett Institute of Oncology, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
  • Besser MJ; Department of Biology, Technion - Israel Institute of Technology, Haifa, Israel.
  • Schachter J; The de Botton Institute for Protein Profiling, The Nancy and Stephen Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, Rehovot, Israel.
  • Golani O; Wellcome Sanger Institute, Cambridge, UK.
  • Segal E; Wellcome Sanger Institute, Cambridge, UK.
  • Geva-Zatorsky N; Faculty of Medicine, University of Zurich Hospital, University of Zurich, Zurich, Switzerland.
  • Ruppin E; The Ella Lemelbaum Institute for Immuno Oncology and Melanoma, Chaim Sheba Medical Center, Tel Hashomer, Israel.
  • Kvistborg P; Department of Clinical Microbiology and Immunology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Peterson SN; The Ella Lemelbaum Institute for Immuno Oncology and Melanoma, Chaim Sheba Medical Center, Tel Hashomer, Israel.
Nature ; 592(7852): 138-143, 2021 04.
Article em En | MEDLINE | ID: mdl-33731925
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos / Bactérias / Antígenos HLA / Melanoma / Antígenos de Bactérias Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Nature Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Israel
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos / Bactérias / Antígenos HLA / Melanoma / Antígenos de Bactérias Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Nature Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Israel